Cells useful for immuno-based Botulinum toxin serotype A activity assays

Details for Australian Patent Application No. 2010223910 (hide)

Owner Allergan, Inc.

Inventors Jacky, Birgitte P.S.; Wang, Joanne; Zhu, Hong; Hodges, D. Dianne; Fernandez-Sales, Ester

Agent Davies Collison Cave

Pub. Number AU-A-2010223910

PCT Pub. Number WO2010/105234

Priority 61/160,199 13.03.09 US

Filing date 12 March 2010

Wipo publication date 16 September 2010

International Classifications

C12N 5/079 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Neural cells

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

15 September 2011 PCT application entered the National Phase

  PCT publication WO2010/105234 Priority application(s): WO2010/105234

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010223911-Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy

2010223890-Dynamic vertebral column plate system